Government of India Notifies New Synthetic Drugs Under NDPS Act-1985

On 16 April 2025, the Ministry of Finance (Department of Revenue), Government of India, issued a series of notifications (S.O. 1729(E), 1730(E), and 1731(E)) amending the Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act). These amendments add several new synthetic substances to the list of manufactured drugs and psychotropic substances. The move reflects India’s commitment to align its domestic laws with evolving patterns of drug abuse and the provisions of the United Nations Convention on Psychotropic Substances, 1971.

Key Notifications

1. S.O. 1729(E): Butonitazene Declared a Manufactured Drug

The Government has classified Butonitazene – chemically known as N, N-Diethyl-2-[(4-butoxyphenyl)methyl]-5-nitro-1H-benzimidazole-1-ethanamine – as a manufactured drug under Section 2(xi)(b) of the NDPS Act.

This classification brings Butonitazene under stringent control for manufacture, possession, sale, transport, and use.
The drug, belonging to the nitazene family of synthetic opioids, has been linked internationally to high abuse potential and overdose risks.

2. S.O. 1730(E): Addition of New Substances to the Schedule of Psychotropic Substances

By exercising powers under Section 3 of the NDPS Act, the Government has inserted new entries after serial number 110ZZE in the Schedule:

110ZZF – 3-Chloromethcathinone (3-CMC)
110ZZG – Dipentylone
110ZZH – 2-Fluorodeschloroketamine
110ZZI – Bromazolam

These substances, used recreationally in several countries, are now officially recognized as psychotropic substances in India, bringing them under regulation for production, trade, and consumption.

3. S.O. 1731(E): Specification of “Small” and “Commercial” Quantities

In continuation of the above inclusions, the Government also amended earlier notifications (notably S.O. 1055(E), dated 19 October 2001) to specify threshold quantities for the newly added drugs:

Substance	Small Quantity	Commercial Quantity
Butonitazene	5 gm	250 gm
3-CMC	5 gm	250 gm
Dipentylone	2 gm	100 gm
2-Fluorodeschloroketamine	5 gm	250 gm
Bromazolam	0.1 gm	5 gm

Small quantity: meant to define personal consumption levels, attracting lighter penalties under the NDPS Act.
Commercial quantity: defines trafficking scale, with much higher punishments including long-term imprisonment.

Significance of the Amendments

Public Health and Safety – Many of these substances are emerging synthetic drugs with high abuse potential, increasingly detected in illicit trafficking worldwide.
Legal Clarity – By listing them explicitly, Indian law enforcement gains the legal authority to prosecute cases of possession, trafficking, and manufacture.
Global Alignment – These amendments bring India’s NDPS regime in line with international conventions and evolving drug trends, especially given the rapid rise of synthetic stimulants and benzodiazepines in underground markets.

Impact on Stakeholders

Law Enforcement: Customs, NCB, and state police agencies now have clear powers to act against offenders dealing with these substances.
Healthcare Sector: Physicians and researchers must exercise caution in handling or studying these substances, as they fall under controlled categories.
Pharmaceutical & Chemical Industries: Any research or legitimate medical use will now require special licenses and compliance with NDPS rules.
Public Awareness: Recreational users and general public need to be aware that possession of even small amounts can attract prosecution.

Conclusion

The 16 April 2025 notifications mark a critical expansion of India’s controlled substances framework, targeting new-age synthetic opioids, stimulants, and sedatives. By bringing Butonitazene, 3-CMC, Dipentylone, 2-Fluorodeschloroketamine, and Bromazolam under the NDPS Act, India strengthens its fight against drug abuse, trafficking, and emerging synthetic narcotics.

In case you face any issues related to Indirect Tax-Customs, GST, Foreign Trade Policy (FTP), Arbitration matters and Central Licensing and related advisory matters in India then please feel free to get in touch with SJ EXIM Services.

We offer Legal advice and litigation support in matters related to Indirect Tax-Customs, FTP, other Indirect Tax matters & Arbitration law, all sorts of Central licensing and related matters. Come and explore the new way of doing business with us!

Source: Ministry of Finance, Govt. of India

Disclaimer

Handy Download:

Ministry of Finance NotificationDownload

Connect with us for more-

@ Team S J EXIM SERVICES, New Delhi, IN

CP: Ms. Shubhra Jha, Founder

Tel: +91-11-4999 2707 I +91-9999005693

Web: www.sjexim.services

EMAIL: operations@sjexim.services I shubhra@sjexim.services

Facebook: www.facebook.com/sjeximservices

LinkedIn: https://www.linkedin.com/company/90794255/admin/feed/posts/

YouTube: https://www.youtube.com/@sjeximIndia

Subscribe our WhatsApp Channel: https://whatsapp.com/channel/0029VaTxDT8JZg4CHEOSoK47

Subscribe our Telegram Channel: https://t.me/sjeximindia

S J EXIM Services